PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020280
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020280
Photodynamic Therapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of photodynamic therapy (PDT) Market
The global photodynamic therapy (PDT) market was valued at USD 2.03 billion in 2025 and is projected to grow to USD 2.18 billion in 2026, eventually reaching USD 4.03 billion by 2034, representing a robust CAGR of 7.97% during the forecast period. North America emerged as the leading regional market in 2025, capturing 37.02% of the global share, driven by the increasing prevalence of chronic diseases, growing patient admissions, and the strategic focus of key players on mergers, acquisitions, and product innovations.
Photodynamic therapy utilizes oxygen, light energy, and photosensitizing agents-either natural or synthetic-that become activated upon light exposure to treat chronic conditions such as cancer, psoriasis, and actinic keratosis. The rising prevalence of chronic disorders, particularly cancer, is driving higher diagnosis and treatment rates, thus fueling the adoption of advanced therapies like PDT.
Market Drivers
The increasing prevalence of chronic diseases is a major growth factor. In the U.S., approximately 1.96 million new cancer cases were projected in 2023, while over 8 million people are affected by psoriasis, reflecting rising demand for effective treatments. Technological advancements, including the integration of nanotechnology, such as quantum dots and biocompatible molecules, are improving PDT efficacy and patient outcomes. Collaborative efforts, such as Photonamic GmbH & Co KG partnering with Lumeda, Inc. in 2023 for lung cancer PDT trials, illustrate the ongoing innovation in the market.
Moreover, minimally invasive procedures are increasingly preferred, prompting key players to develop new photosensitizer drugs and advanced devices that target diseased cells precisely while minimizing harm to healthy tissue.
Market Restraints
Despite these advantages, limited patient awareness, especially in emerging markets, hinders market growth. High treatment costs, around USD 8,500 per PDT procedure, further constrain adoption. Additionally, the availability of alternative therapies reduces the urgency among patients to opt for PDT, particularly in regions with lower healthcare literacy.
Segmentation Analysis
By Product Type:
The PDT market is divided into photosensitizer drugs and photodynamic therapy devices. Photosensitizer drugs dominate with a 65.03% market share in 2026, driven by benefits such as minimal invasiveness and enhanced efficacy. Notable approvals include Bausch + Lomb and Modulight Corporation's VISUDYNE in February 2023. PDT devices, including laser and non-laser systems, are also expected to grow due to AI integration and advanced light sources.
By Application:
The cancer segment led with 54.63% market share in 2026, fueled by rising cancer prevalence and benefits like targeted therapy and reduced damage to healthy cells. Actinic keratosis, psoriasis, and acne segments are expected to grow steadily due to increasing patient awareness and demand for innovative therapies.
By End-User:
Hospitals accounted for the largest segment at 62.73% in 2026, supported by rising patient admissions, reimbursement policies, and increasing adoption of PDT in healthcare facilities. Specialty clinics and other end-users are also witnessing growth due to availability of novel drugs and devices.
Regional Insights
- North America: Valued at USD 0.75 billion in 2025, projected to reach USD 0.81 billion in 2026, with the U.S. market expected at USD 0.73 billion in 2026. Growth is driven by chronic disease prevalence and strategic activities by key players.
- Europe: Marketed at USD 0.58 billion in 2025, projected to reach USD 0.63 billion in 2026, with Germany at USD 0.21 billion and the U.K. at USD 0.15 billion in 2026. Actinic keratosis and other skin disorders drive adoption.
- Asia Pacific: Valued at USD 0.45 billion in 2025, expected at USD 0.48 billion in 2026, with Japan, China, and India contributing significantly due to aging populations and rising chronic disorders.
- Latin America & Middle East & Africa: Latin America was USD 0.15 billion in 2025, reaching USD 0.16 billion in 2026, and the Middle East & Africa contributed USD 0.09 billion in 2025, projected at USD 0.10 billion in 2026. Growth is driven by awareness and novel product launches.
Key Industry Players and Developments
The PDT market is consolidated, with key players like Biofrontera AG (Germany), Lumibird (France), Sun Pharmaceutical Industries Ltd. (India), Galderma (Switzerland), and Bausch + Lomb (Canada) leading. Recent developments include Biofrontera AG's RhodeXL lamp launch in June 2024, Galderma's collaboration with German Medical Engineering in February 2023, and Better Therapeutics' FDA approval for AspyreRx in July 2023.
Conclusion
The global photodynamic therapy market is poised for substantial growth between 2025 and 2034, fueled by rising chronic disease prevalence, technological advancements, and increasing adoption of minimally invasive procedures. While high costs and limited patient awareness pose challenges, strategic collaborations, innovative product launches, and regional expansion are expected to drive the market toward USD 4.03 billion by 2034.
Segmentation By Product Type
- Photosensitizer Drugs
- Oral
- Parenteral
- Photodynamic Therapy Devices
- Laser
- Non-Laser
By Application
- Cancer
- Actinic Keratosis
- Acne
- Psoriasis
- Others
By End-User
- Hospitals
- Specialty Clinics
- Others
By Region
- North America (By Product Type, Application, End-User, and Country)
- U.S.
- Canada
- Europe (By Product Type, Application, End-User, and Country/Sub-region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product Type, Application, End-User, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product Type, Application, End-User, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product Type, Application, End-User, and Country/Sub-region)
- GCC South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025
- 4.2. Technological Advancements in Photodynamic Therapy Devices
- 4.3. New Product Launches
- 4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
- 4.5. Impact of COVID-19 on the Market
5. Global Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product Type
- 5.1.1. Photosensitizer Drugs
- 5.1.1.1. Oral
- 5.1.1.2. Parenteral
- 5.1.2. Photodynamic Therapy Devices
- 5.1.2.1. Laser
- 5.1.2.2. Non-Laser
- 5.1.1. Photosensitizer Drugs
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Cancer
- 5.2.2. Actinic Keratosis
- 5.2.3. Acne
- 5.2.4. Psoriasis
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Hospitals
- 5.3.2. Specialty Clinics
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product Type
- 6.1.1. Photosensitizer Drugs
- 6.1.1.1. Oral
- 6.1.1.2. Parenteral
- 6.1.2. Photodynamic Therapy Devices
- 6.1.2.1. Laser
- 6.1.2.2. Non-Laser
- 6.1.1. Photosensitizer Drugs
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Cancer
- 6.2.2. Actinic Keratosis
- 6.2.3. Acne
- 6.2.4. Psoriasis
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Hospitals
- 6.3.2. Specialty Clinics
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product Type
- 7.1.1. Photosensitizer Drugs
- 7.1.1.1. Oral
- 7.1.1.2. Parenteral
- 7.1.2. Photodynamic Therapy Devices
- 7.1.2.1. Laser
- 7.1.2.2. Non-Laser
- 7.1.1. Photosensitizer Drugs
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Cancer
- 7.2.2. Actinic Keratosis
- 7.2.3. Acne
- 7.2.4. Psoriasis
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia pacific Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product Type
- 8.1.1. Photosensitizer Drugs
- 8.1.1.1. Oral
- 8.1.1.2. Parenteral
- 8.1.2. Photodynamic Therapy Devices
- 8.1.2.1. Laser
- 8.1.2.2. Non-Laser
- 8.1.1. Photosensitizer Drugs
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Cancer
- 8.2.2. Actinic Keratosis
- 8.2.3. Acne
- 8.2.4. Psoriasis
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. Australia
- 8.4.3. China
- 8.4.4. India
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product Type
- 9.1.1. Photosensitizer Drugs
- 9.1.1.1. Oral
- 9.1.1.2. Parenteral
- 9.1.2. Photodynamic Therapy Devices
- 9.1.2.1. Laser
- 9.1.2.2. Non-Laser
- 9.1.1. Photosensitizer Drugs
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Cancer
- 9.2.2. Actinic Keratosis
- 9.2.3. Acne
- 9.2.4. Psoriasis
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product Type
- 10.1.1. Photosensitizer Drugs
- 10.1.1.1. Oral
- 10.1.1.2. Parenteral
- 10.1.2. Photodynamic Therapy Devices
- 10.1.2.1. Laser
- 10.1.2.2. Non-Laser
- 10.1.1. Photosensitizer Drugs
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Cancer
- 10.2.2. Actinic Keratosis
- 10.2.3. Acne
- 10.2.4. Psoriasis
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Hospitals
- 10.3.2. Specialty Clinics
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. BIOFRONTERRA AG
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. LUMIBIRD
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Sun Pharmaceutical Industries Ltd.
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. GALDERMA
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Bausch + Lomb
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Luzitin, S.A.
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Novartis AG
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Modulight Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Theralase Technologies Inc.
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.1. BIOFRONTERRA AG
List of Tables
- Table 1: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 2: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
- Table 3: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
- Table 4: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 5: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 6: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 7: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 8: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
- Table 9: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
- Table 10: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 11: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 12: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 13: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 14: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
- Table 15: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
- Table 16: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 17: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 18: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 19: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 20: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
- Table 21: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
- Table 22: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 23: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 24: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 25: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 26: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
- Table 27: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
- Table 28: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 29: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 30: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 31: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 32: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
- Table 33: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
- Table 34: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 35: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 36: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Photodynamic Therapy Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2025 & 2034
- Figure 3: Global Photodynamic Therapy Market Value Share (%), by Application, 2025 & 2034
- Figure 4: Global Photodynamic Therapy Market Value Share (%), by End User, 2025 & 2034
- Figure 5: Global Photodynamic Therapy Market Value Share (%), by Region, 2025 & 2034
- Figure 6: North America Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 7: North America Photodynamic Therapy Market Value Share (%), by Product Type, 2025
- Figure 8: North America Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
- Figure 9: North America Photodynamic Therapy Market Value Share (%), by Application, 2025
- Figure 10: North America Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
- Figure 11: North America Photodynamic Therapy Market Value Share (%), by End User, 2025
- Figure 12: North America Photodynamic Therapy Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Photodynamic Therapy Market Value Share (%), By Country, 2025
- Figure 14: Europe Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 15: Europe Photodynamic Therapy Market Value Share (%), by Product Type, 2025
- Figure 16: Europe Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
- Figure 17: Europe Photodynamic Therapy Market Value Share (%), by Application, 2025
- Figure 18: Europe Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
- Figure 19: Europe Photodynamic Therapy Market Value Share (%), by End User, 2025
- Figure 20: Europe Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 23: Asia Pacific Photodynamic Therapy Market Value Share (%), by Product Type, 2025
- Figure 24: Asia Pacific Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
- Figure 25: Asia Pacific Photodynamic Therapy Market Value Share (%), by Application, 2025
- Figure 26: Asia Pacific Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
- Figure 27: Asia Pacific Photodynamic Therapy Market Value Share (%), by End User, 2025
- Figure 28: Asia Pacific Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Latin America Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 31: Latin America Photodynamic Therapy Market Value Share (%), by Product Type, 2025
- Figure 32: Latin America Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
- Figure 33: Latin America Photodynamic Therapy Market Value Share (%), by Application, 2025
- Figure 34: Latin America Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
- Figure 35: Latin America Photodynamic Therapy Market Value Share (%), by End User, 2025
- Figure 36: Latin America Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 39: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Product Type, 2025
- Figure 40: Middle East & Africa Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
- Figure 41: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Application, 2025
- Figure 42: Middle East & Africa Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
- Figure 43: Middle East & Africa Photodynamic Therapy Market Value Share (%), by End User, 2025
- Figure 44: Middle East & Africa Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Global Photodynamic Therapy Market Share (%), By Company, 2025
